India Non Invasive Prenatal Testing Market, Test Price and Opportunity Outlook 2024

“India Non Invasive Prenatal Testing Market, Test Price and Opportunity Outlook 2024” Report Highlights:

* Number of NIPT Test at Multiple Adoptability Rates (2018 - 2024)
* Comparative Cost Analysis - NIPT v/s Other Screening Test
* Need and Importance of Prenatal Diagnosis from an Indian Perspective
* Non-Invasive Prenatal Testing Market by Application
* India Non Invasive Prenatal Market Analysis by Product
* Non Invasive Prenatal Market Analysis by Techniques
* India Non Invasive Prenatal Test Market Forecast (2018 - 2024)

Download Sample

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink: https://www.kuickresearch.com/report-india-non-invasive-prenatal-testing-market,-test-price-and-opportunity-outlook-2024.php

Table of Contents

1. Prenatal Diagnosis and Screening - Introduction
1.1 Prologue to Prenatal Diagnosis and Screening
1.2 Historical Insight to Prenatal Diagnosis in India

2. Need and Importance of Prenatal Diagnosis from an Indian Perspective
2.1 Increasing Prevalence of Prenatal Abnormalities
2.2 Increasing Burden of Birth Defects and Mortality
2.3 Rise in Prenatal Disorder Risk Factors in India
2.3.1 Maternal Age at Conception
2.3.2 Proportion of unplanned pregnancies and Lack of antenatal care
2.3.3 Early Marriage and Genetic Condition of the Mother
2.3.4 Rate of Consanguineous Marriage in Population
2.3.5 Exposure of Mother to Possible Teratogens
2.4 Trending of the (Double Income, Single Child) DISC Norm in Indian Society
2.5 Increase in Infertility Rates and In-Vitro Fertilization Centers

3. Non Invasive Prenatal Diagnosis - High Accuracy with No Risks
3.1 Overview
3.2 Risk Associated with Traditional prenatal Screening Methods
3.3 Comparative Analysis of NIPT with other Prenatal Screening Methods

4. Non Invasive Prenatal Testing Market by Application
4.1.1 Down’ Syndrome (Trisomy 21)
4.1.2 Edwards Syndrome (Trisomy 18)
4.1.3 Patau’s Syndrome
4.1.4 Other Chromosomal Abnormalities

5. Superiority of Non Invasive Prenatal screening to Traditional Screening Test
5.1 Painless Procedure with Multiple Benefits
5.2 High Accuracy Even at Earlier Stage of Pregnancy
5.3 No Risk to the Developing Fetus, No Risk of Miscarriage
5.4 Much Higher Detection Rate with Minimum False Positives

6. India Non Invasive Prenatal Market Analysis by Product
6.1 MaterniT21
6.2 Harmony Test
6.3 Visibilit Test
6.4 NIFTY
6.5 Next Generation Sequencing (NGS) System
6.6 Panorama Test
6.7 Polymerase Chain Reaction (PCR) Instrument
6.8 Prenatal Chromosomal Microarray
6.9 Ultrasound and Other Device

7. Non Invasive Prenatal Market Analysis by Techniques
7.1 Ultrasound Detection
7.2 Biochemical screening tests
7.2.1 Human Chorionic Gonadotropin Test
7.2.2 Estriol and Inhibin A Screening
7.3 Cell-free DNA in Maternal Plasma Tests

8. Non Invasive Prenatal Testing Market by End User
8.1 Hospitals
8.2 Laboratories
8.3 In-Vitro Fertilization and Clinics

9. Driving Factors of the Non Invasive Prenatal Testing Market in India

10. Non Invasive Prenatal Testing Market Challenges in India

11. Future Forecast of the Non Invasive Prenatal Testing Market in India

12. Competitive Analysis - Indian NIPT Players
12.1 DNA Labs India
12.1.1 Company Overview
12.1.2 NIPT Products, Services and Cost Analysis
12.2 LifeCell
12.2.1 Company Overview
12.2.2 NIPT Products, Services and Cost Analysis
12.3 LifeCodexx AG
12.3.1 Company Overview
12.3.2 NIPT Products, Services and Cost Analysis
12.4 Apollo Centre for Fetal Medicine, New Delhi
12.4.1 Company Overview
12.4.2 NIPT Products, Services and Cost Analysis
12.5 Medgenome
12.5.1 Company Overview
12.5.2 Product, Services and Cost Analysis
12.6 Igenomix India
12.6.1 Company Overview
12.6.2 Products, Services and Cost Analysis
12.7 Fortis Healthcare Limited
12.7.1 Company Overview
12.7.2 Products, Services and Cost Analysis
12.8 DNA Forensics, India
12.8.1 Company Overview

Figure 1-1: Indications that Highly Demand Prenatal Diagnosis
Figure 1-2: Prenatal Diagnosis in India- History
Figure 2-1: Need and Importance of Prenatal Diagnosis in India
Figure 2-2: Prenatal Diagnosis- Benefits
Figure 2-3: Cause of High Prevalence of Prenatal Disorders in India
Figure 2-4: India - Neonatal Cases of Genetic Disorders (Number of Births), 2015
Figure 2-5: India - Prenatal Mortality due to Congenital Factors (Number/Year)
Figure 2-6: Prenatal Disorders - Risk Factors
Figure 2-7: India - Occurrence of Down's syndrome by Mother’ Age (per 10,000 Births)
Figure 2-8: India - Number of Females Married Before 18, 2014-2016
Figure 2-9: Possible Teratogens That Might Cause Prenatal Abnormalities
Figure 2-10: India - Annual Congenital Malformation (per 10,000 Births), 2015
Figure 2-11: Benefits of Double Income Single Child Norm
Figure 2-12: India - Number of NIPT Test at 10% Adoptability Rate of New Birth (Million) 2018 - 2024
Figure 2-13: India - Number of NIPT Test at 15% Adoptability Rate of New Birth (Million) 2018 - 2024
Figure 2-14: India - Number of NIPT Test at 20% Adoptability Rate of New Birth (Million) 2018 - 2024
Figure 2-15: India - Number of NIPT Test at 30% Adoptability Rate of New Birth (Million) 2018 - 2024
Figure 2-16: Major Factors for Rising Infertility in Indian Couples (%), 2018
Figure 2-17: India - Prevalence of Infertility by Region (%), 2017
Figure 2-18: Global - Infertility status by Region (%), 2018
Figure 3-1: Illustration of Non-Invasive Prenatal Screening Test
Figure 3-2: Goals of Non-invasive Prenatal Screening
Figure 3-3: Comparative Accuracy Analysis - NIPT v/s Other Screening Tests
Figure 3-4: Risks in Amniocentesis and Chorionic Villi Sampling
Figure 3-5: Comparative Cost Analysis - NIPT v/s Other Screening Test (INR), 2018
Figure 3-6: Comparative Cost Analysis - NIPT v/s Other Screening Test(US$), 2018
Figure 4-1: India - NIPT Market Size by Application (%) 2018
Figure 5-1:Non-invasive Prenatal Screening v/s Traditional Screening
Figure 6-1: NIPT Market Size by Product (%), 2018
Figure 6-2: Harmony Test - Price Analysis (INR and US$), 2018
Figure 6-3: Visibility Test - Price Analysis (US$ and INR), 2018
Figure 6-4: NIFTY - Cost Analysis (INR and US$), 2018
Figure 6-5: Genome Sequencing - Cost Analysis (US$ and INR), 2018
Figure 6-6: Panorama Test - Price Analysis (INR and US$), 2018
Figure 6-7: Prenatal PCR - Cost Analysis (INR and US$), 2018
Figure 6-8: Microarray - Cost Analysis (INR and US$), 2018
Figure 6-9: 3D Ultrasound Test - Cost Analysis (US$ and INR), 2018
Figure 6-10: 4D Ultrasound Test - Price Analysis (INR and US$), 2018
Figure 7-1: NIPT - Market Analysis by Techniques (%), 2018
Figure 7-2: MSAFP - Cost Analysis (INR and US$), 2018
Figure 7-3: HCG Biochemical Test - Cost Analysis (INR and US$), 2018
Figure 7-4: Estriol, Inhibin A- Test Cost Analysis (INR and US$), 2018
Figure 8-1: India - NIPT Market Size by End Users (%), 2018
Figure 9-1: Driving Factors of the Indian Prenatal Testing Market
Figure 10-1: Growth Restraining Factors of the Indian Prenatal Testing Market
Figure 11-1: India - Invasive v/s NIPT Market Size (%), 2018
Figure 11-2: India - Prenatal (Invasive and Non Invasive) Test Market Growth Forecast (US$ Million), 2018-2025
Figure 11-3: India Non Invasive Prenatal Test Market Forecast (US$ Million), 2018-2024
Figure 12-1: DNA Labs India - Service and Cost Analysis, 2018
Figure 12-2: Life Cell - Service and Price Analysis, 2018
Figure 12-3: LifeCodexx AG - Service and Cost Analysis, 2018
Figure 12-4: Medgenome - Product Service and Cost Analysis, 2018
Figure 12-5: Igenomix India - Service and Price Analysis, 2018
Figure 12-6: Fortis Healthcare Limited - Products and Service Price Analysis, 2018
Figure 12-7: DNA Forensics - Products and Services Price Analysis, 2018

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.